Changeflow GovPing Healthcare & Life Sciences Monnal T60 Ventilator Recall Air Liquide Medica...
Urgent Enforcement Amended Final

Monnal T60 Ventilator Recall Air Liquide Medical Systems

Favicon for ansm.sante.fr ANSM Drug & Device Safety Alerts
Detected
Email

Summary

ANSM has been informed of a safety action taken by Air Liquide Medical Systems under reference number R2610127, involving the Monnal T60 and Monnal T60 Advanced transport and emergency ventilators. Affected health establishments received a direct communication from the manufacturer on 22/04/2026. Stakeholders with questions are directed to contact Air Liquide Medical Systems directly.

“L'ANSM a été informée de la mise en œuvre d'une action de sécurité effectuée par la société Air Liquide Medical Systems.”

ANSM , verbatim from source
Published by ANSM on ansm.sante.fr . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors ANSM Drug & Device Safety Alerts for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 101 changes logged to date.

What changed

ANSM published a Drug & Device Safety Alert informing health establishments that Air Liquide Medical Systems has implemented a safety action concerning the Monnal T60 and Monnal T60 Advanced transport and emergency ventilators. The action is registered under ANSM reference number R2610127. Users of the affected devices have received a direct communication from the manufacturer.

Healthcare facilities with these ventilators in use should consult the manufacturer letter issued on 22/04/2026 and contact Air Liquide Medical Systems directly for further instructions. As this is a Class I or II-equivalent safety action registered by a Tier B regulatory authority, affected institutions should treat this as requiring priority review.

Archived snapshot

Apr 22, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Information n° R2610127 destinée aux établissements de santé L'ANSM a été informée de la mise en œuvre d’une action de sécurité effectuée par la société Air Liquide Medical Systems.

Les utilisateurs concernés ont reçu le courrier ci-joint.

Cette action de sécurité est enregistrée à l’ANSM sous le n° R2610127. Pour toute question, merci de vous adresser directement à l’émetteur de l’action de sécurité. Téléchargez le courrier de la société Air Liquide Medical Systems (22/04/2026)

Get daily alerts for ANSM Drug & Device Safety Alerts

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from ANSM.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
ANSM
Instrument
Enforcement
Branch
Executive
Source language
fr
Legal weight
Binding
Stage
Final
Change scope
Substantive

Who this affects

Applies to
Healthcare providers Medical device makers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical device recall Device safety action Manufacturer safety communication
Geographic scope
France FR

Taxonomy

Primary area
Medical Devices
Operational domain
Clinical Operations
Compliance frameworks
GxP
Topics
Product Safety Healthcare

Get alerts for this source

We'll email you when ANSM Drug & Device Safety Alerts publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!